Dine at Moe’s and satisfy your thirst for progress

From September 28, 2014, to February 28, 2015, Moe’s Southwest Grill® is holding its cobranded cup campaign at its more than 550 locations. For each regular-sized beverage purchased with a meal, Moe’s will donate to JDRF—with a minimum contribution of $100,000. Moe’s made-to-order, fresh southwestern fare also offers more than 20 gluten-free ingredients and helps […]

2014 Board of Distinction

The Southeastern Wisconsin Chapter of JDRF is proud to announce that we have been awarded with a 2014 Board of Distinction! Over the course of its 43 year history, JDRF has documented and established best practices that are shared by successful chapter boards across the organization. Boards that achieve these norms are recognized with the […]

Unlocking a Combination Therapy for New Onset T1D

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

2015 Ride Registration Opens January 21st!

Registration for the 2015 JDRF Ride to Cure Diabetes dates opens on Wednesday, January 21st at 12:00pm CST! Join the JDRF Southeastern Wisconsin Chapter, one of the largest Ride to Cure Diabetes chapters throughout the organization, as we travel to the following locations on our mission to cure T1D: Burlington, VT- July 23-26 LaCrosse, WI- […]

Kids Walk Intern Opportunity!

The JDRF Southeastern Wisconsin Chapter is offering an internship opportunity for an enthusiastic college-aged student to help with the Kids Walk to Cure Diabetes program this spring! The JDRF Kids Walk program is an educational, in-school fundraising program with two goals: 1) to educate students about type 1 and type 2 diabetes and the importance […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Make Your Year End, Tax Deductible Gift

With type 1 diabetes (T1D) there are no holidays off. This holiday season, help us create a world without type 1 diabetes. Donate Now JDRF’s mission is to find a cure for type 1 diabetes (T1D) and its complications through the support of research. Every dollar we are able to direct toward this critical research […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Historic Progress for JDRF Encapsulation Research Program

First people with type 1 diabetes receive experimental encapsulated cell replacement therapies in clinical studies Two JDRF-funded partners have successfully implanted people with type 1 diabetes (T1D) with experimental encapsulated cell replacement therapies in clinical studies. These two programs are running in parallel and are evaluating two distinct encapsulation therapies. Encapsulated cell replacement therapy involves […]

It’s Time to Redefine Type 1 Diabetes

Last month, JDRF co-hosted a workshop where healthcare experts from government, nonprofit agencies and educational institutions discussed expanding the definition of Type 1 Diabetes (T1D) to recognize the earliest stages of human T1D before a person is clinically symptomatic. The benefits of the proposed system could include potentially faster drug development, identification of people living […]